Search research articles
Contact Us
Filters
Showing results (131-140 of 154) with videos related to
Page
of 16
Sort By:
American Journal of Hematology
|
March 28, 2026
Thirty Years of Classical Hematology Drugs in the US: Approvals, Costs, and Sales
Lucas T Go, Lewis T Go, Michelle A Elliott, et al.
Cancer Causes & Control : CCC
|
November 25, 2015
Family history of hematologic malignancies and risk of multiple myeloma: differences by race and clinical features
MaryAnn E VanValkenburg, Gwendolyn I Pruitt, Ilene K Brill, et al.
Blood Advances
|
August 12, 2025
Assessment of Classical Hematologists and Classical Hematology Fellowship Programs at NCI-Designated Cancer Centers
Lewis T Go, Lucas T Go, Madugodaralalage Dsk Gunaratne, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
November 29, 2021
Comparison of Cilta-cel, an Anti-BCMA CAR-T Cell Therapy, Versus Conventional Treatment in Patients With Relapsed/Refractory Multiple Myeloma
Luciano J Costa, Yi Lin, R Frank Cornell, et al.
Histology and Histopathology
|
June 10, 2005
Karyotypic analysis of adult pluripotent stem cells
N L Henson, M L Heaton, B H Holland, et al.
Blood
|
September 22, 2023
Tafasitamab and lenalidomide in large B-cell lymphoma: real-world outcomes in a multicenter retrospective study
David A Qualls, Nicholas Lambert, Paolo F Caimi, et al.
Hemasphere
|
November 20, 2025
Outcomes of tafasitamab and lenalidomide in large B-cell lymphoma based on prior CD19-directed CAR T exposure
Mwanasha H Merrill, Robert A Redd, Nicholas Lambert, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
January 6, 2022
NCCN Guidelines® Insights: Multiple Myeloma, Version 3.2022
Natalie S Callander, Muhamed Baljevic, Kehinde Adekola, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
January 18, 2023
Systemic Light Chain Amyloidosis, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology
Shaji K Kumar, Natalie S Callander, Kehinde Adekola, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
December 7, 2020
Multiple Myeloma, Version 3.2021, NCCN Clinical Practice Guidelines in Oncology
Shaji K Kumar, Natalie S Callander, Kehinde Adekola, et al.
Page
of 16
Search research articles
Search
Showing results (131-140 of 154) with videos related to
Sort By:
Page
of 16
American Journal of Hematology
|
March 28, 2026
Thirty Years of Classical Hematology Drugs in the US: Approvals, Costs, and Sales
Lucas T Go, Lewis T Go, Michelle A Elliott, et al.
Cancer Causes & Control : CCC
|
November 25, 2015
Family history of hematologic malignancies and risk of multiple myeloma: differences by race and clinical features
MaryAnn E VanValkenburg, Gwendolyn I Pruitt, Ilene K Brill, et al.
Blood Advances
|
August 12, 2025
Assessment of Classical Hematologists and Classical Hematology Fellowship Programs at NCI-Designated Cancer Centers
Lewis T Go, Lucas T Go, Madugodaralalage Dsk Gunaratne, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
November 29, 2021
Comparison of Cilta-cel, an Anti-BCMA CAR-T Cell Therapy, Versus Conventional Treatment in Patients With Relapsed/Refractory Multiple Myeloma
Luciano J Costa, Yi Lin, R Frank Cornell, et al.
Histology and Histopathology
|
June 10, 2005
Karyotypic analysis of adult pluripotent stem cells
N L Henson, M L Heaton, B H Holland, et al.
Blood
|
September 22, 2023
Tafasitamab and lenalidomide in large B-cell lymphoma: real-world outcomes in a multicenter retrospective study
David A Qualls, Nicholas Lambert, Paolo F Caimi, et al.
Hemasphere
|
November 20, 2025
Outcomes of tafasitamab and lenalidomide in large B-cell lymphoma based on prior CD19-directed CAR T exposure
Mwanasha H Merrill, Robert A Redd, Nicholas Lambert, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
January 6, 2022
NCCN Guidelines® Insights: Multiple Myeloma, Version 3.2022
Natalie S Callander, Muhamed Baljevic, Kehinde Adekola, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
January 18, 2023
Systemic Light Chain Amyloidosis, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology
Shaji K Kumar, Natalie S Callander, Kehinde Adekola, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
December 7, 2020
Multiple Myeloma, Version 3.2021, NCCN Clinical Practice Guidelines in Oncology
Shaji K Kumar, Natalie S Callander, Kehinde Adekola, et al.
Page
of 16